RABL5 Human

RAB, Member RAS Oncogene Family-Like 5 Human Recombinant
Shipped with Ice Packs
In Stock

Description

Functional Roles

RABL5 exhibits distinct roles in membrane trafficking and ciliary biology:

Intraflagellar Transport (IFT) and Ciliogenesis

  • Ciliary Transport: RABL5 colocalizes with IFT proteins at the basal body and flagellum matrix in Trypanosoma brucei. RNAi knockdown results in truncated flagella, indicating a role in anterograde IFT .

  • BBSome Recruitment: In humans, RABL5 interacts with BBS3 (a BBSome component) to recruit the BBSome to cilia, a process essential for ciliogenesis. Defects in this interaction contribute to Bardet-Biedl syndrome (BBS) .

Membrane Trafficking

While less characterized than Rab5, RABL5 may participate in endosomal dynamics. Recombinant RABL5 binds GTP/GDP, suggesting regulatory roles in vesicle fusion or transport .

Ciliopathies

  • Bardet-Biedl Syndrome (BBS): RABL5 recruits the BBSome to cilia via its interaction with BBS3. Disruption of this pathway leads to defective cilia, causing obesity, retinal dystrophy, and polydactyly .

  • IFT Mutants: In T. brucei, RABL5 RNAi results in short flagella filled with IFT proteins, mimicking retrograde IFT defects .

Neuronal Functions

  • mRNA Transport: The FERRY complex (a Rab5 effector) links mRNA to early endosomes, but analogous roles for RABL5 remain unexplored. Its involvement in neural activities (e.g., rapid protein turnover) is hypothesized due to its high-energy demand .

Comparative Analysis with Rab5

While RABL5 shares structural homology with Rab5, functional divergence exists:

FeatureRABL5Rab5
Primary LocalizationBasal body, cilia matrix Early endosomes, plasma membrane
Key InteractionsBBS3, IFT proteins Rabaptin-5, EEA1, FHF complex
Disease LinkBardet-Biedl syndrome, ciliopathies Neurodegeneration, retrograde transport defects

Experimental Tools and Applications

  • Recombinant Protein: Available for structural studies (e.g., SDS-PAGE, Western blot) .

  • RNAi Models: Used to study ciliogenesis in T. brucei and human cells .

  • Cryo-EM Studies: Structural insights into Rab5 effectors (e.g., FERRY complex) may inform RABL5’s mechanisms .

Product Specs

Introduction
RABL5 (RAB, Member RAS Oncogene Family-Like 5) is a small GTP-binding protein belonging to the Ras superfamily. This superfamily consists of various subfamilies, including R-Ras, Rap, Ral/Rec, and Rho/Rab. Rab proteins play a crucial role in the transportation of newly synthesized proteins. This process involves moving these proteins from the endoplasmic reticulum through the Golgi complex to secretory vesicles using carrier vesicles, a process requiring Rab protein functionality.
Description
Recombinant RABL5 Human, produced in E. coli, is a single, non-glycosylated polypeptide chain. It consists of 208 amino acids (amino acids 1-185) and has a molecular weight of 23.2 kDa. The protein includes a 23 amino acid His-tag fused at the N-terminus and is purified using proprietary chromatographic techniques.
Physical Appearance
A clear, colorless solution that has been sterile filtered.
Formulation
The RABL5 solution has a concentration of 0.5 mg/mL and contains 20 mM Tris-HCl buffer with a pH of 8.0, 0.1 M NaCl, 10% glycerol, and 1 mM DTT.
Stability
For short-term storage (2-4 weeks), keep at 4°C. For longer storage, freeze at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
Purity is greater than 95% as determined by SDS-PAGE analysis.
Synonyms
Rab-like protein 5 isoform a, Rab-like protein 5, RABL5, RAB, Member RAS Oncogene Family-Like 5.
Source
E.coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSMLKAKIL FVGPCESGKT VLANFLTESS DITEYSPTQG VRILEFENPH VTSNNKGTGC EFELWDCGGD AKFESCWPAL MKDAHGVVIV FNADIPSHRK EMEMWYSCFV QQPSLQDTQC MLIAHHKPGS GDDKGSLSLS PPLNKLKLVH SNLEDDPEEI RMEFIKYLKS IINSMSESRD REEMSIMT.

Q&A

What is RABL5 (IFT22) and what is its basic function in human cells?

RABL5, also known as IFT22, is a member of the Rab-like protein family that belongs to the larger Ras superfamily of small GTPases. These proteins are characterized by their ability to bind and hydrolyze GTP, functioning as molecular switches in various cellular processes. While specific information about RABL5 is limited in current literature, it appears to be involved in intracellular trafficking processes, similar to other Rab family proteins such as Rab5, which mediates the retrieval of surface receptors from the axon to contribute to neuronal polarity .

Research methodology for studying RABL5's basic function typically involves:

  • Protein localization studies using fluorescently-tagged RABL5 constructs

  • Co-immunoprecipitation to identify binding partners

  • RNA interference or CRISPR-Cas9 gene editing to observe loss-of-function phenotypes

  • GTPase activity assays to characterize enzymatic properties

What experimental systems are most suitable for studying RABL5 human protein?

When selecting experimental systems for RABL5 research, consider the following methodological approaches:

  • Cell culture systems:

    • Human cell lines (HEK293T, HeLa, neuronal cell lines if studying in neuronal context)

    • Primary human cells relevant to hypothesized function

  • Protein expression systems:

    • Recombinant protein can be produced in HEK293T cells as demonstrated in available research

    • E. coli or baculovirus-insect cell systems for larger-scale protein production

  • Model organisms:

    • Consider mammalian models for in vivo studies

    • If studying evolutionary conservation, simpler model organisms may be appropriate

The selection should be guided by your specific research questions. For basic characterization, cell culture systems offer controlled conditions and accessibility. For physiological relevance, primary cells or animal models provide more complex contexts.

How should I design controls for RABL5 protein expression experiments?

Proper experimental design for RABL5 protein expression studies requires rigorous controls to ensure valid and reproducible results :

Positive controls:

  • Well-characterized Rab family proteins with established expression patterns

  • Previously validated RABL5 constructs (if available)

  • Include a positive control for transfection/transduction efficiency (e.g., GFP expression vector)

Negative controls:

  • Empty vector controls to account for effects of transfection reagents

  • Non-targeting siRNA/shRNA for knockdown experiments

  • Inactive mutant versions (e.g., GTP-binding deficient mutants)

Technical considerations:

  • Include biological replicates (n≥3) to account for biological variability

  • Employ randomized block designs to control for confounding variables like passage number or plate position effects

  • Implement appropriate statistical analysis methods based on experimental design (e.g., ANOVA for multi-factor experiments)

Validation should include Western blotting with appropriate antibodies or detection of tags if using recombinant constructs. Quantification should be performed using image analysis software with appropriate normalization to loading controls.

How can I investigate the role of RABL5 in intracellular trafficking analogous to other Rab proteins?

Based on knowledge of related Rab proteins like Rab5, which contributes to neuronal polarity through mediating receptor retrieval from axons , designing experiments to investigate RABL5's trafficking role requires:

Methodological approach:

  • Subcellular localization studies:

    • Generate fluorescently-tagged RABL5 constructs

    • Perform co-localization studies with markers for specific organelles (endosomes, Golgi, etc.)

    • Use live-cell imaging to track RABL5-positive vesicles in real-time

  • Interaction network characterization:

    • Identify potential effectors using proximity labeling approaches (BioID, APEX)

    • Confirm interactions with co-immunoprecipitation followed by mass spectrometry

    • Validate key interactions using yeast two-hybrid or FRET-based assays

  • Functional perturbation:

    • Generate GTP-locked (constitutively active) and GDP-locked (inactive) mutants

    • Perform cargo trafficking assays comparing wild-type and mutant RABL5

    • Use quantitative microscopy to measure transport kinetics

  • Spatial-temporal regulation:

    • Implement optogenetic approaches to control RABL5 activity with precise timing

    • Use FRAP (Fluorescence Recovery After Photobleaching) to measure dynamics

The experimental design should include appropriate statistical analyses such as factorial ANOVA for experiments with multiple variables, accounting for interaction effects between factors .

What approaches can resolve contradictory data when studying RABL5 protein interactions?

When faced with contradictory findings regarding RABL5 protein interactions, implement a systematic approach to resolve discrepancies:

  • Methodological triangulation:

    • Apply multiple, complementary techniques to validate interactions:

      • In vitro: Pull-down assays with purified components

      • Cellular: Co-IP, proximity labeling, FRET/BRET

      • In vivo: Co-localization in relevant tissues

  • Conditional dependency analysis:

    • Test whether interactions are dependent on:

      • GTP/GDP-bound state of RABL5

      • Cell type or tissue context

      • Presence of cofactors or scaffold proteins

      • Post-translational modifications

  • Quantitative analysis:

    • Move beyond qualitative (present/absent) to quantitative assessments

    • Apply quantitative interaction proteomics

    • Use mixed-methods research design combining qualitative and quantitative approaches

  • Systematic review of experimental conditions:

    • Create a comprehensive table comparing:

VariableExperiment 1Experiment 2Experiment 3
Cell/tissue typeHEK293TNeuronal cellsIn vitro
Detection methodCo-IP/WesternMass spectrometryStructural biology
RABL5 formWild-typeTagged versionNucleotide-bound state
Buffer conditionsHigh saltPhysiologicalDetergent present
Statistical approacht-testANOVARegression

This structured approach allows identification of conditional factors that might explain contradictory results, following sound experimental design principles .

How can I design experiments to elucidate RABL5's potential role in neuronal polarity similar to Rab5?

Given that Rab5 contributes to neuronal polarity by mediating retrieval of surface receptors from the axon , investigating whether RABL5 has analogous functions requires sophisticated experimental design:

Experimental approach:

  • Comparative localization and dynamics:

    • Generate fluorescently-tagged RABL5 and Rab5 constructs

    • Perform time-lapse imaging in primary neurons to compare localization and transport dynamics

    • Quantify axonal vs. dendritic distribution using compartmentalized culture systems

  • Cargo identification and tracking:

    • Implement proximity labeling to identify potential RABL5-associated cargoes in neurons

    • Use dual-color live imaging to simultaneously track RABL5 and identified cargoes

    • Analyze co-transport events using kymograph analysis and particle tracking

  • Functional perturbation studies:

    • Design split-plot experimental design with between-subject factor (control vs. RABL5 knockdown) and within-subject factor (axonal vs. dendritic measurements)

    • Measure effects on:

      • Receptor distribution (somatodendritic vs. axonal)

      • Retrograde transport from axon to soma

      • Interaction with motor proteins like dynein-dynactin complexes

  • Mechanistic investigation:

    • Test whether RABL5 interacts with FHF complex components that mediate Rab5's effects

    • Examine whether RABL5 participates in coupling axonal retrograde carriers to dynein-dynactin

Statistical analysis should employ mixed-effects models to account for the hierarchical nature of the data (multiple measurements within neurons, neurons within cultures) .

What are the optimal conditions for expressing and purifying recombinant RABL5 human protein?

Successful expression and purification of recombinant RABL5 requires optimization of several parameters:

Expression system selection:

  • HEK293T cells have been successfully used for RABL5/IFT22 expression as evidenced by Coomassie blue staining of purified protein

  • For structural studies requiring higher yields, consider:

    • Bacterial systems (E. coli) with optimized codons

    • Baculovirus-insect cell system for post-translational modifications

Optimization parameters:

  • Expression construct design:

    • Include appropriate affinity tags (His, GST, MBP)

    • Consider tag position (N- vs. C-terminal) based on protein structure

    • Include TEV/PreScission protease sites for tag removal

  • Expression conditions:

    • Test multiple induction conditions if using bacterial systems

    • Optimize transfection efficiency for mammalian expression

    • Consider temperature, duration, and media composition

  • Purification strategy:

    • Two-step purification recommended: affinity chromatography followed by size exclusion

    • Buffer optimization:

Buffer ComponentScreening RangeRationale
pH7.0-8.0Physiological range for stability
NaCl150-500 mMPrevent non-specific interactions
Reducing agent1-5 mM DTT/TCEPMaintain cysteine residues
Nucleotide±GTP/GDPStabilize specific conformations
Glycerol0-10%Additional stability for storage
  • Quality control:

    • Verify purity using SDS-PAGE with Coomassie staining

    • Confirm identity with mass spectrometry

    • Assess structural integrity using circular dichroism

    • Validate activity through GTPase assays

What quantitative approaches should I use to analyze RABL5 localization in subcellular compartments?

Quantitative analysis of RABL5 subcellular localization requires robust imaging and analytical methodologies:

Data collection strategies:

  • High-resolution imaging:

    • Confocal microscopy for 3D localization

    • Super-resolution techniques (STED, PALM/STORM) for co-localization with other proteins

    • Consider live-cell imaging for dynamic studies

  • Experimental design considerations:

    • Employ randomized complete block design to control for batch effects

    • Include multiple biological and technical replicates

    • Use appropriate controls for antibody specificity or fluorescent protein localization

Quantitative analysis methods:

  • Colocalization analysis:

    • Pearson's or Mander's correlation coefficients

    • Object-based colocalization for discrete structures

    • Intensity correlation analysis

  • Relative distribution metrics:

    • Calculate ratio of intensities between compartments

    • Generate intensity line profiles across cellular regions

    • Apply threshold-based segmentation followed by feature extraction

  • Advanced analytical approaches:

    • Machine learning classification of localization patterns

    • Bayesian analysis for probabilistic assignment to compartments

Statistical considerations:

  • Apply factorial ANOVA to analyze effects of multiple experimental factors

  • For repeated measures designs (e.g., time-course studies), use appropriate repeated measures models with sphericity corrections if needed

  • Control for multiple comparisons using Bonferroni or false discovery rate methods

When comparing conditions, report effect sizes and confidence intervals in addition to p-values to provide meaningful interpretation of biological significance.

How can I design robust experiments to study RABL5 involvement in specific cellular pathways?

Designing robust experiments to investigate RABL5's role in cellular pathways requires careful consideration of experimental design principles:

Experimental design framework:

  • Define clear hypotheses and objectives:

    • Formulate specific, testable hypotheses about RABL5's function

    • Determine primary outcomes and secondary endpoints

    • Consider potential confounders based on known functions of related proteins

  • Select appropriate experimental design:

    • For comparing multiple factors, use factorial designs to detect interaction effects

    • For time-course experiments, implement repeated measures designs with appropriate controls for time-dependent effects

    • For complex designs with both between-subject and within-subject factors, consider split-plot designs

  • Power analysis and sample size determination:

    • Conduct a priori power analysis to determine appropriate sample size

    • Consider effect sizes from pilot studies or related published work

    • Plan for potential data loss or experimental failure

  • Controls and validation strategies:

    • Include multiple complementary approaches:

      • Loss-of-function: siRNA, CRISPR knockout/knockdown

      • Gain-of-function: overexpression of wild-type and mutant forms

      • Rescue experiments to confirm specificity

    • Employ positive and negative controls for each technique

  • Data analysis plan:

    • Pre-specify primary statistical analyses

    • Consider mixed-methods approaches combining qualitative and quantitative data

    • Plan for testing assumptions (normality, homogeneity of variance) and alternative analyses if assumptions are violated

  • Validation experiments:

    • Plan orthogonal methods to validate key findings

    • Consider both in vitro and in vivo approaches where appropriate

    • Design experiments to test causality, not just correlation

Following these methodological principles will strengthen the validity and reproducibility of findings regarding RABL5's involvement in specific cellular pathways.

How should I approach conflicting results in RABL5 localization studies between different cell types?

When facing conflicting RABL5 localization data across different cell types, implement a systematic analytical approach:

Methodological strategy:

  • Determine if differences are biological or technical:

    • Create a comprehensive comparison table:

AspectCell Type ACell Type BCell Type C
Detection methodAntibody XTagged proteinAntibody Y
Fixation protocolPFA, 10 minMethanol, 5 minPFA, 15 min
Imaging techniqueConfocalWidefieldSuper-resolution
Quantification methodManual scoringAutomated segmentationColocalization coefficients
Statistical approacht-testANOVANon-parametric
  • Validate with multiple detection methods:

    • Compare antibody-based detection with fluorescently-tagged proteins

    • Use multiple antibodies targeting different epitopes

    • Validate specificity through knockdown/knockout controls

  • Implement cross-validation experiments:

    • Apply identical protocols across cell types

    • Exchange key reagents between laboratories if multiple groups are involved

    • Use mixed factorial design to systematically test effects of cell type, detection method, and their interaction

  • Consider biological explanations:

    • Cell-type specific expression of RABL5 interactors or regulators

    • Differences in post-translational modifications

    • Variations in cellular architecture affecting distribution patterns

  • Statistical considerations:

    • Use appropriate statistical tests for comparing distributions

    • Consider hierarchical/nested designs if analyzing multiple fields per experiment

    • Implement robust statistical methods if data violate parametric assumptions

By systematically addressing both technical and biological factors, you can determine whether localization differences represent genuine biological variation or methodological artifacts.

What statistical approaches are most appropriate for analyzing RABL5 protein-protein interaction data?

Analyzing protein-protein interaction data for RABL5 requires selecting appropriate statistical methods based on the experimental approach:

Statistical frameworks for different interaction data types:

  • Binary interaction data (Y2H, co-IP):

    • Fisher's exact test for comparing detection frequencies

    • McNemar's test for paired comparisons (e.g., wild-type vs. mutant)

    • Log-linear models for multi-factor experiments

  • Quantitative interaction data (FRET, BLI, SPR):

    • One-way or factorial ANOVA for comparing multiple conditions

    • Consider repeated measures ANOVA for within-sample comparisons

    • Linear mixed models for complex experimental designs with random effects

  • High-throughput interaction screening:

    • Implement appropriate multiple testing corrections (FDR, Bonferroni)

    • Consider Bayesian approaches to estimate false discovery rates

    • Apply network analysis algorithms to identify significant interactions

  • Dose-response or kinetic data:

    • Non-linear regression for fitting appropriate models (e.g., binding curves)

    • Compare curve parameters (Kd, Bmax) using extra sum-of-squares F test

    • Consider global fitting approaches for complex datasets

Experimental design considerations:

  • For factorial designs, ensure statistical models properly account for main effects and interactions

  • For complex designs, consider consultation with a biostatistician during planning stages

  • Pre-register analysis plans to avoid post-hoc decision bias

Validation and reporting:

  • Report effect sizes and confidence intervals, not just p-values

  • Include appropriate visualizations (interaction plots for factorial designs )

  • Consider bootstrapping or permutation tests for robustness

  • Follow field-specific standards for reporting interaction data

How can I integrate multi-omics data to comprehensively understand RABL5 function in human cells?

Integrating multi-omics data to elucidate RABL5 function requires sophisticated computational and analytical approaches:

Multi-omics integration framework:

  • Data collection strategy:

    • Ensure compatible experimental design across platforms

    • Include:

      • Proteomics: Interactome, post-translational modifications

      • Transcriptomics: Expression changes upon RABL5 manipulation

      • Imaging data: Localization and trafficking dynamics

      • Functional assays: Phenotypic outcomes of perturbation

  • Data pre-processing for integration:

    • Apply platform-specific normalization methods

    • Address batch effects using methods like ComBat or RUV

    • Transform data to comparable scales when necessary

    • Implement missing data strategies appropriate for each data type

  • Integration methods:

    • Network-based approaches:

      • Construct multi-layered networks connecting proteins, genes, and phenotypes

      • Apply network algorithms to identify modules and key connectors

      • Use path analysis to discover potential mechanistic links

    • Statistical integration:

      • Apply canonical correlation analysis (CCA) or multi-omics factor analysis

      • Consider Bayesian data integration frameworks

      • Implement DIABLO or similar multi-block analysis methods

    • Machine learning approaches:

      • Use supervised methods to identify features predictive of RABL5 function

      • Apply dimensionality reduction techniques for visualization

      • Consider deep learning for complex pattern recognition

  • Biological interpretation:

    • Perform pathway enrichment analysis on integrated results

    • Compare findings with known functions of related proteins like Rab5

    • Generate testable hypotheses about novel functions or mechanisms

  • Validation strategy:

    • Design experimental validation of key predictions

    • Implement mixed-methods research approach combining quantitative and qualitative data

    • Use orthogonal techniques to confirm key findings

This integrated approach leverages diverse data types to build a comprehensive understanding of RABL5 function, potentially revealing roles in cellular processes like those observed for related proteins in neuronal polarity and intracellular trafficking .

What are the best approaches for studying the GTPase cycle of RABL5 and its regulatory mechanisms?

Investigating the GTPase cycle of RABL5 requires specialized biochemical and biophysical techniques:

Methodological framework:

  • Biochemical characterization:

    • GTPase activity assays:

      • Radioactive approaches: [γ-32P]GTP hydrolysis

      • Non-radioactive methods: HPLC-based, colorimetric (malachite green), or fluorescent (FRET-based)

    • Nucleotide binding assays:

      • Fluorescent nucleotide analogs (mant-GTP/GDP)

      • Isothermal titration calorimetry

      • Surface plasmon resonance

  • Structural approaches:

    • X-ray crystallography of RABL5 in different nucleotide-bound states

    • Cryo-EM for larger complexes with regulatory proteins

    • NMR for dynamic studies of conformational changes

  • Identification of regulatory factors:

    • GEFs (Guanine nucleotide Exchange Factors):

      • In vitro nucleotide exchange assays with candidate proteins

      • Pull-down assays using nucleotide-depleted RABL5

    • GAPs (GTPase Activating Proteins):

      • Enhanced GTPase activity assays in presence of candidates

      • Co-IP experiments comparing GTP/GDP-locked mutants

  • Cellular dynamics:

    • FRAP (Fluorescence Recovery After Photobleaching) to assess cytosol/membrane cycling

    • Biosensors to visualize GTP-bound RABL5 in live cells

    • Optogenetic approaches to acutely manipulate GTPase cycle

  • Experimental design considerations:

    • Include appropriate controls (non-hydrolyzable GTP analogs, inactive mutants)

    • Design factorial experiments to test multiple factors influencing activity

    • Use randomized complete block designs to control for batch effects in biochemical assays

Through systematic application of these approaches, you can elucidate the regulatory mechanisms controlling RABL5's GTPase cycle and identify key factors that modulate its activity in cellular contexts.

How can I design CRISPR/Cas9 experiments to study RABL5 function while minimizing off-target effects?

Designing precise CRISPR/Cas9 experiments for RABL5 functional studies requires careful consideration of several methodological aspects:

Comprehensive experimental design:

  • Guide RNA design strategy:

    • Use multiple validated algorithms to predict efficient gRNAs

    • Select guides with minimal predicted off-target sites

    • Consider the following criteria:

      • Target essential functional domains

      • Avoid polymorphic regions

      • Select guides with high on-target and low off-target scores

  • Experimental validation of editing:

    • On-target verification:

      • Perform targeted sequencing of the RABL5 locus

      • Use T7E1 or Surveyor assays as initial screens

      • Confirm mutations at protein level when possible

    • Off-target analysis:

      • Sequence predicted off-target sites

      • Consider unbiased approaches (GUIDE-seq, CIRCLE-seq)

      • Perform whole-genome sequencing for critical experiments

  • Control strategies:

    • Essential controls:

      • Non-targeting gRNA controls

      • Multiple independent gRNAs targeting different RABL5 regions

      • Rescue experiments with gRNA-resistant RABL5 constructs

    • Enhanced specificity approaches:

      • Use high-fidelity Cas9 variants (eSpCas9, HF-Cas9)

      • Consider Cas9 nickase with paired gRNAs

      • Optimize Cas9 and gRNA delivery to minimize exposure time

  • Experimental design optimization:

    • Implement factorial or randomized block designs to control for batch effects

    • Consider clone-to-clone variability in analysis

    • Plan appropriate statistical approaches for comparing edited cells to controls

  • Advanced genetic approaches:

    • For subtle manipulations:

      • Design HDR templates for point mutations in key functional residues

      • Create conditional alleles using floxed strategies

      • Generate endogenously tagged versions for localization studies

By implementing these methodological strategies, you can maximize specificity while minimizing confounding off-target effects in RABL5 functional studies using CRISPR/Cas9 technology.

What are the most appropriate cell models for studying RABL5's potential role in specialized cellular processes?

Selecting appropriate cellular models for RABL5 studies requires matching model systems to specific research questions:

Systematic model selection framework:

  • Basic characterization studies:

    • Immortalized human cell lines:

      • HEK293T cells (documented for RABL5/IFT22 expression)

      • HeLa cells for trafficking and localization studies

      • U2OS cells for high-resolution imaging due to flat morphology

  • Neuronal function studies:
    Given Rab5's role in neuronal polarity , if investigating similar functions for RABL5:

    • Primary neuronal cultures:

      • Rat/mouse hippocampal neurons (well-established polarity models)

      • Human iPSC-derived neurons for human-specific biology

    • Neuronal cell lines:

      • SH-SY5Y (can be differentiated to neuron-like cells)

      • PC12 cells (for growth factor response studies)

  • Specialized cellular functions:

    • Polarized epithelial cells:

      • MDCK cells for apical/basolateral trafficking studies

      • Caco-2 cells for intestinal epithelial models

    • Immune cells:

      • THP-1 (monocyte/macrophage functions)

      • Jurkat (T-cell signaling and trafficking)

  • Advanced model systems:

    • 3D culture systems:

      • Organoids for tissue-specific functions

      • Spheroids for polarized structures

    • Co-culture systems:

      • Neuron-glia co-cultures for cell-cell interactions

      • Endothelial-epithelial co-cultures for barrier functions

  • Experimental design considerations:

    • Implement appropriate controls (parental cell lines, isogenic controls)

    • Use factorial designs when testing RABL5 function across multiple cell types

    • Consider mixed-effects models for statistical analysis when using heterogeneous primary cultures

When selecting cell models, consider experimental tractability, available genetic tools, physiological relevance, and consistency with previous studies in the field. The choice should be guided by the specific aspect of RABL5 biology under investigation, with appropriate justification in your experimental design.

How can I optimize transfection conditions for RABL5 expression constructs in different cell types?

Optimizing transfection for RABL5 expression across different cell types requires systematic evaluation of multiple parameters:

Methodological optimization framework:

  • Pre-transfection considerations:

    • Construct design optimization:

      • Codon optimization for target cell types

      • Appropriate promoter selection (cell-type specific vs. strong constitutive)

      • Vector backbone selection based on size and stability requirements

    • Cell preparation:

      • Optimize seeding density (typically 70-90% confluency at transfection)

      • Determine optimal cell cycle phase (usually mid-log growth phase)

      • Minimize passage number variations between experiments

  • Transfection method selection:

    • For HEK293T cells (known to express RABL5/IFT22) :

      • Lipid-based transfection (Lipofectamine, FuGENE)

      • Calcium phosphate precipitation (cost-effective)

      • PEI (polyethylenimine) for larger scale expressions

    • For neuronal cells (if studying RABL5 in neuronal context like Rab5) :

      • Nucleofection (Amaxa/Lonza)

      • Viral transduction (lentivirus, AAV)

      • Calcium phosphate with glycerol shock for primary neurons

    • For difficult-to-transfect cells:

      • Electroporation with cell-specific protocols

      • Viral transduction

      • Nanoparticle-based methods

  • Optimization strategy:

    • Implement factorial design to simultaneously test multiple variables :

ParameterLevel 1Level 2Level 3
DNA amount0.5 μg1.0 μg2.0 μg
Reagent:DNA ratio2:13:14:1
Cell density70%80%90%
Incubation time4h6h24h
  • Evaluation metrics:

    • Expression level:

      • Western blot quantification

      • Flow cytometry for percentage of positive cells and expression level

      • Fluorescence microscopy for tagged constructs

    • Cell health:

      • Viability assays (MTT, alamarBlue)

      • Proliferation rate post-transfection

      • Morphological assessment

  • Statistical analysis:

    • Apply factorial ANOVA to identify significant main effects and interactions

    • Use response surface methodology for fine-tuning optimal conditions

    • Implement randomized block design to control for batch effects

By systematically optimizing these parameters using sound experimental design principles, you can achieve consistent and efficient expression of RABL5 constructs across different cell types.

What are the recommended protocols for immunoprecipitation of endogenous RABL5 to study protein interactions?

Immunoprecipitation of endogenous RABL5 requires careful optimization to preserve physiologically relevant interactions:

Comprehensive IP protocol framework:

  • Antibody selection and validation:

    • Test multiple antibodies against different epitopes of RABL5

    • Validate specificity by Western blot and immunofluorescence

    • Consider:

      • Monoclonal antibodies for specificity

      • Polyclonal antibodies for potentially better capture

      • Confirm recognition of native (non-denatured) protein

  • Cell lysis optimization:

    • Buffer composition options:

    ComponentStandard RangeConsiderations
    Detergent0.5-1% NP-40/Triton X-100Milder detergents preserve interactions
    Salt100-150 mM NaClHigher salt reduces non-specific binding
    pH7.2-8.0Physiological range
    Protease inhibitorsComplete cocktailEssential to prevent degradation
    Phosphatase inhibitorsCocktailIf studying phosphorylation
    GTPγS/GDP100 μMTo stabilize specific conformations
    • Lysis conditions:

      • Temperature (4°C throughout procedure)

      • Duration (minimize time, typically 15-30 min)

      • Mechanical disruption methods (if needed)

  • Immunoprecipitation procedure:

    • Pre-clearing strategy:

      • Incubate lysate with beads alone to remove non-specific binders

      • Use matched IgG controls for background subtraction

    • IP approaches:

      • Direct antibody coupling to beads (reduces antibody bands in eluate)

      • Antibody followed by Protein A/G beads

      • Consider crosslinking antibody to beads for cleaner results

    • Washing optimization:

      • Number of washes (typically 3-5)

      • Washing buffer stringency (detergent and salt concentration)

      • Implement randomized block design for testing washing conditions

  • Elution and analysis:

    • Elution methods:

      • Denaturing (SDS sample buffer, boiling)

      • Native (epitope peptide competition)

      • Acidic glycine buffer for antibody-antigen dissociation

    • Detection methods:

      • Western blotting for known/expected interactors

      • Mass spectrometry for unbiased interaction discovery

      • Targeted proteomics for quantitative comparison between conditions

  • Controls and validation:

    • Essential controls:

      • IgG control IP (same species as RABL5 antibody)

      • RABL5 knockdown/knockout cells for antibody specificity

      • Input samples (typically 5-10% of IP input)

    • Validation strategies:

      • Reverse IP (IP interactor, detect RABL5)

      • Proximity labeling methods (BioID, APEX) as orthogonal validation

      • Co-localization studies to confirm spatial proximity

This methodological framework provides a starting point for optimizing immunoprecipitation of endogenous RABL5, which can be adapted based on specific research questions and cell types under investigation.

What experimental design considerations are important when comparing wild-type and mutant forms of RABL5?

Comparing wild-type and mutant RABL5 proteins requires careful experimental design to ensure valid and interpretable results:

Comprehensive experimental design framework:

  • Mutation design strategy:

    • Functional mutations based on Rab GTPase knowledge:

      • GTP-binding deficient (e.g., S/N mutations in P-loop)

      • GTPase-deficient (constitutively active, Q/L mutations)

      • Effector binding interface mutations

      • Consider analogous mutations to those characterized in related proteins like Rab5

    • Expression construct considerations:

      • Matched expression levels (same promoter, vector backbone)

      • Identical tags (position and type) for fair comparison

      • Codon optimization standardized across constructs

  • Experimental design structure:

    • For multiple mutants and conditions, implement:

      • Factorial design to detect interaction effects

      • Include time as a factor for dynamic processes

      • Consider split-plot designs for complex experiments with both between-subject and within-subject factors

    • Control for confounding variables:

      • Cell density and passage number

      • Transfection efficiency (co-transfect reporter)

      • Expression level variations (FACS sorting or expression normalization)

  • Statistical considerations:

    • Sample size determination:

      • Conduct power analysis based on pilot data

      • Consider biological and technical replicates distinctly

      • Plan for appropriate statistical tests (t-tests, ANOVA, etc.)

    • Randomization and blinding:

      • Randomize sample processing order

      • Blind analysis when possible (especially for imaging)

      • Implement randomized block design to control for batch effects

  • Key phenotypic comparisons:

    • Comprehensive phenotypic analysis:

    AspectWild-typeMutant 1Mutant 2Mutant 3
    Subcellular localization
    Protein interactions
    GTPase activity
    Functional readouts
    Cellular phenotypes
  • Rescue experiments:

    • Design strategies:

      • Knockdown endogenous RABL5 followed by re-expression

      • Use siRNA-resistant constructs

      • Consider inducible expression systems

      • Employ orthogonal gene editing approaches

    • Analysis approaches:

      • Quantify degree of phenotypic rescue

      • Apply appropriate statistical tests (often ANOVA with post-hoc comparisons)

      • Implement mixed-methods approach for comprehensive assessment

By systematically addressing these experimental design considerations, you can generate robust and reproducible comparisons between wild-type and mutant RABL5 proteins, leading to more reliable functional insights.

Product Science Overview

Gene and Protein Information
  • Gene Name: RABL5
  • Protein Name: RABL5, Member RAS Oncogene Family-Like 5
  • Gene Family: Ras superfamily of small GTPases
  • Function: The RABL5 protein binds to both GTP and GDP, playing a crucial role in cellular processes such as vesicular traffic and protein transport .
Biological Role

RABL5 is involved in the regulation of vesicular trafficking, ensuring the fidelity of docking and fusion of vesicles with their correct acceptor compartments. This process is essential for maintaining cellular homeostasis and proper functioning of various cellular pathways .

Clinical Significance

Overexpression of RABL5 has been implicated in certain types of cancer, including breast cancer. The protein’s role in cell growth and survival makes it a potential target for therapeutic interventions .

Recombinant RABL5

Recombinant RABL5 is produced using recombinant DNA technology, which involves inserting the RABL5 gene into a suitable expression system to produce the protein in large quantities. This recombinant protein is used in various research applications to study its function and role in disease processes .

Applications in Research

Recombinant RABL5 is utilized in:

  • Protein-Protein Interaction Studies: To understand how RABL5 interacts with other proteins within the cell.
  • Drug Development: As a target for developing new therapeutic agents.
  • Functional Assays: To study the biological activity of RABL5 and its role in cellular processes .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.